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ing benign from malignant musculoskeletal soft-tissue masses using ADC mapping as a quantitative
assessment tool.
Patients and methods: We evaluated 73 tumors (21 bone tumors and 52 soft-tissue tumors). MR
examinations were performed with a 1.5-T system. Diffusion-weighted single-shot EPI images were
obtained in all patients. Apparent diffusion coefﬁcients (ADCs) were calculated by using b factors600614.
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220 S.A. Khedr et al.of 0 and 1000 s/mm2. ADC value measurements were compared with the histopathological ﬁndings.
Results: The average ADC of benign tumors was 1.86 ± 0.67 · 103 mm2/s, and that of malignant
soft-tissue tumors was 0.97 ± 0.35 · 103 mm2/s. ADC value of malignant tumors was signiﬁcantly
lower than that of the benign tumor group (p< 0.0001). The highest ADC value was seen in the
case of ganglion cyst (2.8 ± 0.23 · 103 mm2/s) and cystic neuroﬁbroma (2.5 ± 0.04 · 103 mm2/
s), and juxta cortical enchondroma (2.65 ± 0.36 · 103 mm2/s) while the lowest one was seen in
aggressive ﬁbromatosis (0.37 ± 0.05 · 103 mm2/s). For malignant soft-tissue masses, the highest
ADC value was seen in mesenchymal chondrosarcoma (2.1 ± 0.32) liposarcoma (intermediate
grade) (1.4 ± 0.21) while the lowest ADC value was seen in ﬁbrosarcoma (high grade)
(0.78 ± 0.14).
Conclusion: MR diffusion provides additional information to the routine MRI sequences rendering
it an effective non-invasive tool in differentiating between benign and malignant soft-tissue tumors.
 2012 Egyptian Society of Radiology and Nuclear Medicine. Production and hosting by Elsevier B.V.
Open access under CC BY-NC-ND license.1. Introduction
Diffusion-weighted magnetic resonance imaging (MRI) re-
ﬂects intra-voxel incoherent motion (IVIM). In biological tis-
sues, motion includes Brownian motion of extra-, intra-, and
trans-cellular individual water molecules (true diffusion) as
well as microcirculation of blood (perfusion) (1). Both true
diffusion and perfusion contribute to the frequently used
apparent diffusion coefﬁcient (ADC). Diffusion-weighted
MRI has been used successfully in the central nervous sys-
tem (CNS), especially in the diagnosis of acute stroke
(2–4), but also in distinguishing different components of
brain tumors (5,6). Diffusion measurements of tumors out-
side the brain have also been reported. A study of osteogenic
sarcoma by Schnapauff et al. (7) indicates that diffusion-
weighted MRI can accurately differentiate between viable
and necrotic tumor regions. Maier et al. (8) reported quanti-
tative diffusion measurements of breast tumors in mice.
Moreover, Baur et al. (9) reported diffusion measurements
in human spine that could reliably differentiate acute benign
from neoplastic vertebral compression fractures. These stud-
ies have demonstrated potential for providing information
that can contribute to the differentiation between benign
and malignant tumors, and can identify various tumor com-
ponents (9).
The purpose of this study is to evaluate the diagnostic im-
pact of echo planar DW imaging in distinguishing benign from
malignant musculoskeletal soft-tissue masses using ADC map-
ping as a quantitative assessment tool.2. Patients and methods
2.1. Patients
From December 2008 to November 2010, we prospectively in-
cluded 73 consecutive patients (23 females and 50 males; age
range 11–70 years; median age 41 years) with clinically sus-
pected musculoskeletal neoplasm. The patients were subjected
to clinical examination, previous X-ray and ultrasonography
examination. In all patients diagnosis was conﬁrmed after
MRI with histologic biopsy and/or examination of the resected
specimens. We evaluated 73 tumors (27 bone tumors and 46
soft-tissue tumors).2.2. MR imaging technique
All patients underwent MRI using a 1.5-T MR system (Mag-
netom Symphony, Syngo 1.5 T Siemens) with the following
pulse sequences.
Standard protocols for musculoskeletal system:
(1) T1WI (TR/TE/NEX; 450/15/1; FOV, 20–30) in axial,
coronal and sagittal planes.
(2) Fast spin-echoT2WI (TR/TE/NEX); 3000–3500/100–
120/2; FOV, 20–30) in axial, coronal and sagittal planes.
(3) Short inversion recovery (STIR) (TR/TE/TI/NEX);
5000–5300/30–50/160/2; FOV, 20–30) in axial, coronal
and sagittal planes.
(4) Gradient recalled echo (GRE)(TR/TE/NEX;700–750/
20–30/2; FOV,20–30) with ﬂip angle 15–30 in axial,
coronal or sagittal planes.
(5) Post-contrast T1WI SE and T1-fat suppressed images in
axial, coronal and sagittal planes using gadolinium
D.T.P.A (0.1 mmol/kg body weight).
(6) Diffusion weighted images
A diffusion-weighted spin-echo sequence with peripheral
pulse triggering (TR – 2-RR, TE – 70, ﬂip angle – 90, ﬁeld
of view (FOV) – 200–300 mm, matrix size – 51–128) was used
with diffusion gradient strengths yielding ﬁve b values ranging
from 0 to 701 s/mm2 (b – 0, 176, 351, 526, and 701 s/mm2).
Six slices through the tumor were acquired with a slice
thickness of 5 mm and an inter slice gap of 2.5 mm
Body parts containing the tumors were immobilized to pre-
vent motion artifacts.
Arbitrarily shaped regions of interest (ROIs) for data anal-
ysis was positioned in tumor on the basis of the T2-weighted
reference image (b – 0 s/mm2) and copied to all isotropic
images of subsequent b-values.
When multiple tumor components (solid vs. cystic) could
be identiﬁed, measurements were taken in the solid compo-
nents. The mean signal intensities on ﬁve isotropic images ob-
tained with different b-values were used to calculate the ADC
values.
Differences in ADC values between malignant and benign
soft-tissue masses were evaluated using Student’s t-test. p
values less than 0.05 were considered a statistically
signiﬁcant.
cba
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Fig. 1 Ganglion cyst on the lateral aspect of the wrist appears of low signal in axial T1WIs(a), high signal in axial T2WIs and fat
suppression sequence (b,c), with no appreciable l contrast enhancement in fat suppression T1WIs(d) . No restriction in DWI(e,f) and
ADC. ADC Value 2.8 ± 0.23.
Table 1 The number and ADC value of benign masses.
Benign lesions Number Main ADC value measurements (mm2/s)
Hemangioma 6 1.4 ± 0.18–1.6 ± 0.2 · 103
Juxtacortical enchondroma 2 2.65 ± 0.36 · 103
Ganglion 7 1.9 ± 0.212.8 ± 0.23 · 103
Schwannoma 5 1.5 ± 0.19 · 103
Neuroﬁbroma 3 1.75 ± 0.26 · 103
Cystic neuroﬁbroma 1 2.5 ± 0.04 · 103
Aggressive ﬁbromatosis 2 0.37 ± 0.05 · 103
Osteochondroma 3 2.1 ± 0.34 · 103
Elastoﬁbroma 2 1.9 ± 0.24 · 103
PVN 2 2.21 ± 0.14 · 103
Total 33 1.86 ± 0.67 · 103
Table 2 The number and ADC value of malignant masses.
Malignant Tumors Number Main ADC value measurements (mm2/s)
Low grade sarcoma 6 1.1 ± 0.22 · 103
Intermediate liposarcoma 2 1.4 ± 0.21 · 103
High grade liposarcoma 2 0.97 ± 0.18 · 103
Intermediate ﬁbrosarcoma 3 1.0 ± 0.2 · 103
High grade ﬁbro sarcoma 2 0.78 ± 0.14 · 103
Malignant ﬁbrous histiocytoma 2 0.81 ± 0.18 · 103
Neuroﬁbrosarcoma 1 0.96 ± 0.17 · 103
Metastatic deposits 6 0.9 ± 0.18 · 103
Ewing’s sarcoma 4 1.1 ± 0. 9 · 103
Giant cell tumor 6 1.1 ± 0. 5 · 103
Osteosarcoma 5 0.9 ± 0. 6 · 103
Mesenchymal chondrosarcoma 1 2.1 ± 0. 32 · 103
Total 40 0.97 ± 0.35 · 103
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Fig. 2 Juxtacortical Enchondroma of the humeral head appears
of low signal in axial T1WIs(a), heterogenous high signal in axial
T2WIs and fat suppression sequence (b,c), with No restriction in
DWI and ADC (d) ADC Value 2.65 ± 0.36.
b
c
d e
a
Fig. 3 Cystic Neuroﬁbroma appears of low signal in coronal
T1WIs(a), high signal in axial T2WIs and fat suppression sequence
(b,c). No restriction in DWI(d,e) and ADC. ADC Value
2.5 ± 0.04.
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Seventy-three patients (50 males and 23 females) were in-
cluded in this study. Their ages range from 11 to 70 years;
median age 41 years. The diagnosis of the soft-tissue masses
was conﬁrmed with histopathologic examination after exci-
sion biopsy (in 61 patients) or post-surgical excision (in 12
patients). 33 masses were benign and 40 masses were malig-
nant. Twenty-one bone tumors and 52 soft-tissue tumors
(Tables 1 and 2).
The average ADC of benign cases was 1.86 ±
0.67 · 103 mm2/s, and that of malignant soft-tissue tumors
was 0.97 ± 0.35 · 103 mm2/s. ADC value of malignant tu-
mors was signiﬁcantly lower than that of the benign tumor
group (p< 0.0001). The highest ADC value was seen in the
case of ganglion cyst (2.8 ± 0.23 · 103 mm2/s) (Fig. 1), juxta
cortical enchondroma (2.65 ± 0.36 · 103 mm2/s) (Fig. 2) and
cystic neuroﬁbroma (2.5 ± 0.04 · 103 mm2/s) (Fig. 3) while
the lowest one was seen in aggressive ﬁbromatosis
(0.37 ± 0.05 · 103 mm2/s) (Fig. 4). For malignant soft-tissue
masses, the highest ADC value was seen in mesenchymal
chondrosarcoma (2.1 ± 0.32 · 103 mm2/s) and liposarcoma
(intermediate grade) (1.4 ± 0.21) (Fig. 5) while the lowest
ADC value was seen in ﬁbrosarcoma (high grade)
(0.78 ± 0.14) (Fig. 6), GCT (Fig. 7), osteosarcoma (Fig. 8),
and Ewing’s sarcoma (Fig. 9), showed intermediate ADC.4. Discussion
Magnetic resonance imaging has an important role in diagno-
sis, staging and follow-up of soft-tissue masses owing to its
precise visualization of degenerative changes, tumor and
inﬂammatory disease.
Tissue contrast attained by using diffusion-weighted mag-
netic resonance (MR) imaging is different from that attained
by using conventional MR techniques. The diffusion technique
involves the diffusion motion of water protons in the tissues,
and this technique produces different contrast in different
kinds of tissue. Therefore, the ﬁndings of this procedure can
provide different information about diseased tissues (4). Re-
cently DWI was used to characterize soft-tissue tumor, differ-
entiate between benign and malignant soft-tissue masses.
Our results demonstrate increased apparent diffusion coef-
ﬁcients in benign soft-tissue masses compared to malignant
soft-tissue masses where the main ADC value of all benign
soft-tissue masses was 1.86 ± 0.67 while the main ADC value
for all malignant soft-tissue masses was 0.97 ± 0.35. This may
be attributed to the increased diffusion of water molecules in
Fig. 4 Aggressive ﬁbromatosis of the ankle appearing of low
signal in coronal T1 and T2WIs(a&b) with non uniform contrast
enhancement in post contrast axial T1WIs(c) high restriction in
ADC(d). ADC Value 0.37 ± 0.05.
b a c 
e d 
Fig. 5 Mesenchyma chondrosarcoa of the calcaneus appears of high signal in sagittal STIR, T2 fat supression (a,b)) with non uniform
contrast enhancement in post contrast sagittal T1WIs. restriction in DWI(d,e) and ADC. ADC Value 2.1 ± 0. 32.
b a 
c d 
Fig. 6 Liposarcoma of the thigh.The soft tissue component
appears of high signal in sagittal fat suppression sequence (a) and
intensely enhancing in sagittal T1 fat suppression(b) and showing
restriction in DWI(c,d) and ADC . ADC Value 1.1 ± 0. 13.
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Fig. 7 GCT of the distal femur appears of high signal in coronal
fat suppression (a), low signalinn sagittall T1WIs(b). No restric-
tion in DWIc,(d) and ADC. ADC Value 1.2 ± 0.
ba 
d c 
Fig. 8 Osteosarcoma of the forearm appears of low signal in
sagittal T1WIs(a),heterogenos high signal in sagittal T2WIs (b))
Area of restriction in DWI(c,d) and ADC. ADC Value 0.9 ± 0.6.
224 S.A. Khedr et al.the extracellular spaces in benign lesions as compared to that
of malignant soft-tissue masses. These results were comparable
to those of Nagata et al. (10) who stated that the size of the
extracellular space is the most important component of the
true diffusion measurement in soft-tissue tumors. A larger or
less restricted extracellular space, allowing spin dephasing
and loss of signal on diffusion-weighted images, is the most
likely explanation for the increased diffusion of most benign
soft-tissue tumors. Malignant soft-tissue tumors tend to have
lower true diffusion measurements due to increased tumor cell
packing in the majority of the malignant soft-tissue tumors,
resulting in the restriction of Brownian motion in the extracel-
lular space (11–12).
Our results revealed that ganglion cyst and cystic neuroﬁ-
broma (Figs. 1 and 3) and juxtacortical enchnodroma
(Fig. 2) had higher ADC values than those other benign
soft-tissue lesions (Table 1). For malignant soft-tissue masses,
the highest ADC value was seen in mesenchymal chondrosar-
coma (2.1 ± 0.32 · 103 mm2/s) and liposarcoma (intermedi-
ate grade) (1.4 ± 0.21). These results were comparable with
those of Nagata et al. (10) who stated that ADC values of myx-
omatous, cystic, and cartilaginous components are signiﬁ-
cantly higher than those of other tumors and even malignant
cartilaginous tumor ADC values are higher than those of be-
nign tumors.
Previous studies reported that not all benign soft-tissue tu-
mors have a large extracellular space, and not all malignant
soft-tissue tumors are more cellular than benign soft-tissue tu-
mors. There was a considerable variation in true diffusion val-
ues within a group of liposarcomas and between the high- andlow-grade myxoﬁbrosarcomas. A possible explanation may be
related to the various histologic subtypes and variation in the
degree of tumor differentiation. Another explanation is that
the ADC value is affected not only by cellularity but also by
the amount and type of extracellular substance. Soft-tissue tu-
mors, as opposed, for example, to brain tumors, are a highly
heterogeneous entity as regards extracellular matrix. Some
of the benign and malignant soft tissue tumoursshow such
heterogeniety as may explain the overlapping of ADC values.
(13–15).
In the current study the two patients with benign lesions,
demonstrating very low ADC value (0.37 ± 0.05) similar to
ADC values of malignant soft-tissue tumors, had aggressive
ﬁbromatosis (Fig. 4). This can be explained by the fact that,
histologically, aggressive ﬁbromatosis consists of relatively
uniform spindle-shaped cells surrounded and separated from
each other by collagen ﬁbers. However, ﬁbrosarcoma is also
composed of a relatively uniform population of spindle cells,
demonstrating variable anaplasia. Fibrosarcoma is differenti-
ated from aggressive ﬁbromatosis by increased collagen and
the absence of atypia in the latter, which is beyond the reach
of diffusion-weighted MRI (16).
Several techniques have been used to obtain diffusion-
weighted MR images (13). We used a peripheral pulse-trig-
gered conventional spin-echo sequence that corrects for, or
minimizes the effects of vascular pulsation on MR images in
the extremities, and which was described previously as a suc-
cessful sequence for diffusion measurements (17,18). The main
disadvantage of the spin-echo sequence is the long acquisition
Fig. 9 Ewing’s sarcoma of the ﬁbula appears of low signal in
sagittal T1WIs(a), contrast enhancement inpost contrast fat
suppression sequence (b) . Restriction in DWI(c,d) and ADC.
ADC Value 1.1 ± 0. 9
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facts. Faster imaging sequences, such as echo planar tech-
niques, are available and have been used for diffusion
measurements in the human brain (17), hepatic lesions (19),
and in the pelvis (20,21). Steady state free precession (SSFP)
techniques have also been used in the musculoskeletal system
for diffusion weighted MRI, with reported adequate image
quality, SNRs, and relatively short acquisition times. The main
disadvantages of the SSFP technique are the difﬁculties in
quantifying diffusion, T2-contamination, and other confound-
ing relaxation effects. Apparently, further studies are war-
ranted to achieve faster diffusion-weighted spin-echo and/or
EPI sequences with adequate image quality for diffusion mea-
surements in the musculoskeletal system (22,23).
Limitations in our study were that lacking of some of the
musculoskeletal tumor histologies, which make it difﬁcult to
know if our results are matching to all tumors or not, and also
the difﬁculty in comparison of our results with those of others
due to differences in imaging sequences and differences in b-
values.
In conclusion, diffusion measurements of soft-tissue masses
have potential as a non-invasive tool in the differentiation of
benign and malignant soft-tissue lesions. It provides important
additional information, but does not serve as a substitute for
the routine MRI sequences. Further prospective studies with
larger patient populations are required.References
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